Bibliography
- Elias JA, Kang MJ, Crothers K, et al. State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice. Proc Am Thorac Soc 2006;3(6):494-8
- Wang Z, Zheng T, Zhu Z, et al. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 2000;192:1587-600
- Valença SS, Da HORA, K CASTRO, et al. Emphysema and metalloelastase expression in mouse lung induced by cigarette smoke. Toxicol Pathol 2004;32(3):351-6
- Churg A, Wang R, Wang X, et al. Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax 2007;62(8):706-13
- Demedts IK, Morel-Montero A, Lebecque S, et al. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 2006;61(3):196-201
- Srivastava PK, Dastidar SG, Ray A. Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy. Expert Opin Invest Drugs 2007;16(7):1069-78
- Drummond AH, Beckett P, Brown PD, et al. Preclinical and clinical studies of MMP inhibitors in cancer. Ann NY Acad Sci 1999;878:228-35
- Woessner JF Jr. Matrix metalloproteinase inhibition. From the Jurassic to the third millennium. Ann NY Acad Sci 1999;878:388-403
- Fingleton B. MMPs as therapeutic targets–still a viable option? Semin Cell Dev Biol 2008;19(1):61-8
- Pirard B. Insight into the structural determinants for selective inhibition of matrix metalloproteinases. Drug Discov Today 2007;12(15-16):640-6
- AstraZeneca AB. Novel 2, 5-dioxoimidazolidin-4-yl acetamides and analogues useful as MMP-12 inhibitors for the treatment of obstructive airway disorders. WO2004020415
- MMP-12 inhibitors. Exp Opin Ther Pat 2004;14:1637-40
- Ranbaxy Laboratories Ltd. New 5-phenylpentanoic acid derivatives are dual MMP-9 /12 inhibitors – useful for the treatment of inflammatory diseases. WO2006090235
- Applied Research Systems Holding NV. New N-hydroxyamide derivatives are MMP-2, MMP-9 and/or MMP-12 inhibitors – useful for the treatment of eg multiple sclerosis, liver fibrosis and COPD. WO2007060132
- Jiangsu Hengrui Medicine Co Ltd. Medivir AB New (2,5-dioxoimidazolidin-1-yl)-N-hdroxy-acetamides are MMP-12 inhibitors – useful for treating obstructive airway diseases. WO2007068474
- Novartis AG. New hydroxamic acid derivatives are MMP inhibitors – useful for the treatment of eg asthma, COPD, atherosclerosis, cancer, periodontal disease, endometriosis and heart failure. WO2007117981
- Warner-Lambert Company Llc New 5-fluoro-thiophene compounds are MMP-12 and/or MMP-13 inhibitors – useful for treating respiratory diseases, cancer, arthritis and cardiovascular disease. WO2005003114
- Morales R, Perrier S, Florent JM, et al. Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12. J Mol Biol 2004;341(4):1063-76
- Lavigne MC, Eppihimer MJ. Cigarette smoke condensate induces MMP-12 gene expression in airway-like epithelia. Biochem Biophys Res Commun 2005;330(1):194-203
- Markus MA, Dwyer B, Wolfrom S, et al. Solution structure of wild-type human matrix metalloproteinase 12 (MMP-12) in complex with a tight-binding inhibitor. J Biomol NMR 2008;41(1):55-60
- Le Quément C, Guénon I, Gillon JY, et al. The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke. Br J Pharmacol 2008;154(6):1206-15
- Stenvall K, Gabos B, Lundkvist M, et al. Development of hydroxy hydantoins, a novel class of MMP-12 inhibitors, for treatment of COPD 234th ACS National Meeting, 2007; MEDI 26
- AstraZeneca AB. New crystalline Form G of (5S)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonylmethyl]-5-methyl-imidazolidine-2,4-dione – useful as an MMP-12 inhibitor for the treatment of inflammation and COPD. WO2007106022
- AstraZeneca AB. Combination product comprising a hNE inhibitor and a metalloproteinase inhibitor – useful for treating respiratory disease such as COPD and asthma. WO2008053199
- Savio DA, Halpern AR, Wu Y, et al. Abstract 3718: MMP-12 Inhibitor Reduces Severity of ANGII-induced Aortic Abdominal Aneurysms in apoE–/– Mice. Circulation 2008;118:S473